• BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.

    百泌达是FDA批准的治疗2型糖尿病的首个GLP- 1受体激动剂药物。

    youdao

  • Direct injection of an adenosine A1 receptor agonist replicated the analgesic effect of acupuncture.

    直接注射腺苷a 1受体拮抗剂能够复制针灸的镇痛效果。

    youdao

  • BYDUREON and BYETTA belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications.

    BYDUREON和百泌达(BYETTA)都属于胰高血糖素样肽(GLP - 1)受体激动剂类药物。

    youdao

  • Provided herein is a method of reversing or preventing a target cell's resistance to a death receptor agonist.

    本文提供了反转或阻止靶细胞对死亡受体激动剂的抗性的方法。

    youdao

  • RESULTS:Pharmacological evaluation showed that Pergolide mesylate is a specific dopminergic DA receptor agonist.

    结果:药理评价显示甲磺酸培高利特是一典型D受体激动剂。

    youdao

  • Objective to observe the effect of excitatory amino acids receptor agonist on the onset of puberty in female rats.

    目的研究兴奋性氨基酸受体激动剂对雌性大鼠青春期启动的影响。

    youdao

  • Objective: To evaluate and compare the effects of DA 1 receptor agonist, fenoldopam, rabbit pulmonary and mesenteric arteries.

    目的:对比分析多巴胺1受体激动剂非诺多泮对兔肺动脉和肠系膜动脉的影响。

    youdao

  • The P2Y receptor agonist may be administered with therapeutic and adjuvant agents commonly used to treat edematous retinal disorders.

    上述P 2y受体拮抗剂可以和通常用于治疗水肿性视网膜疾病的治疗剂和佐剂一起施用。

    youdao

  • Objective: to study the protecting effect of delayed preconditioning with A1 selective adenosine receptor agonist in donor heart preservation.

    目的:探讨腺苷a1受体激动剂延迟预处理对大鼠心脏的保护效果。

    youdao

  • OBJECTIVE To investigate the protective effects of M3 receptor agonist pilocarpine on myocardial ischemia-reperfusion injury in isolated rat hearts.

    目的研究M3受体激动剂毛果芸香碱对离体大鼠心肌缺血再灌注损伤的保护作用。

    youdao

  • The pharmaceutical composition useful in this invention comprises a P2Y receptor agonist with enhanced resistance to extracellular hydrolysis, such as dinucleoside polyphosphate compounds.

    所述对本发明有效的药物组合物含有对胞外水解有增强抗性的P2Y受体激动药,如二核苷酸多磷酸化合物。

    youdao

  • Objective To investigate the possible neuroprotective effect of dopamine(DA) receptor agonist R-apomorphine(R-APO) on the 6-hydroxydopamine(6-OHDA)-induced rat model of Parkinson's disease.

    目的探讨阿扑吗啡是否对6-羟基多巴胺毁损纹状体帕金森病鼠模型有神经保护作用。

    youdao

  • Since varenicline is only a partial agonist—not a full agonist—at the alpha4beta2 receptor site, it performs differently in smokers and nonsmokers, she said.

    对alpha4beta2受体来说,既然伐伦克林仅是部分激动剂--不是完全激动剂,它对吸烟者和非吸烟者的作用是不同的,她说。

    youdao

  • A noncompetitive antagonist prevents the agonist from producing any effect at a given receptor site.

    非竞争性拮抗剂可阻止激动剂在特定受体部位产生任何效应。

    youdao

  • With study development of CCK receptor antagonist and agonist, people have deep understanding about CCK's physiological function.

    CCK受体激动剂与拮抗剂的研究深入,促进了人们对CCK生理功能的深入认识。

    youdao

  • CONCLUSION Geniposide has the similar function as the agonist for GLP-1 receptor, including neurotrophic and neuroprotective effects.

    结论京尼平苷具有与GLP - 1受体激动剂类似的神经营养和神经保护功能。

    youdao

  • This is most effective if a specific receptor blocking agent is available to counter the effects of a given agonist.

    在这方面最有效的是利用特效的受体阻滞药对抗特定激剂的作用。

    youdao

  • AIM: to investigate the role of protease-activated receptor-2 (PAR-2) agonist in the formation and pathogenesis of stress ulcer.

    目的:探讨大鼠蛋白酶激活受体- 2在应激性溃疡中的作用。

    youdao

  • To investigate the role of cytokines, we blocked cytokine release by using GTS-21, a selective agonist of the 7 nicotinic acetylcholine receptor.

    为研究细胞因子的作用,我们使用GTS - 21(烟碱乙酰胆碱受体7的一种选择性激动剂)来阻断细胞因子的释放。

    youdao

  • The invention relates to a multi- peptide agonist vitro screening method of the glucagon peptide-1 receptor and the screened multi- peptide.

    本发明涉及胰高血糖素样肽-1受体的多肽类激动剂的体外筛选方法及筛选得到的 多肽。

    youdao

  • The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity.

    本发明提供了具有胰高血糖素受体拮抗剂活性或反向激动剂活性的、新颖的式i化合物及其药学上可接受的盐和共晶体。

    youdao

  • Objective:To synthesize BP897, a dopamine D3 receptor partial agonist.

    前言: 目的:合成多巴胺D,受体部分激动剂BP897。

    youdao

  • A noncompetitive antagonist prevents the agonist from producing any effect at a given receptor site...

    非竞争性拮抗剂可阻止激动剂在特定受体部位产生任何效应。

    youdao

  • A noncompetitive antagonist prevents the agonist from producing any effect at a given receptor site...

    非竞争性拮抗剂可阻止激动剂在特定受体部位产生任何效应。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定